Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Ordinary Shares, NIS 1.80 par value per share
Symbol
GLMD on Nasdaq
Shares outstanding
5,591,387
Price per share
$0.84
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
221,660
Total reported value
$166,356
% of total 13F portfolios
0%
Share change
+147,936
Value change
+$111,011
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 3.1% -57% $346,666 173,333 0% CVI Investments, Inc. 30 Sep 2025
Baharaff Allen 2.6% $60,455 44,128 Allen Baharaff 31 Dec 2024

As of 31 Dec 2025, 16 institutional investors reported holding 221,660 shares of Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD). This represents 4% of the company’s total 5,591,387 outstanding shares.

Institutional Holders of Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 221,660 $166,356 +$111,011 $0.75 16
2025 Q3 72,824 $102,011 -$18,462 $1.38 13
2025 Q2 75,987 $140,174 +$46,243 $1.86 14
2025 Q1 55,876 $80,439 +$15,875 $1.44 12
2024 Q4 44,767 $142,806 +$124,943 $3.19 11
2024 Q3 5,585 $38,313 +$38,306 $6.86 9